Artivion, Inc. (AORT)
NYSE: AORT · IEX Real-Time Price · USD
19.80
-0.80 (-3.88%)
Apr 30, 2024, 3:14 PM EDT - Market open
Artivion Revenue
In the year 2023, Artivion had annual revenue of $354.00M with 12.82% growth. Revenue in the quarter ending December 31, 2023 was $93.67M with 17.98% year-over-year growth.
Revenue (ttm)
$354.00M
Revenue Growth
+12.82%
P/S Ratio
2.41
Revenue / Employee
$236,003
Employees
1,500
Market Cap
826.27M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 354.00M | 40.22M | 12.82% |
Dec 31, 2022 | 313.79M | 14.95M | 5.00% |
Dec 31, 2021 | 298.84M | 45.61M | 18.01% |
Dec 31, 2020 | 253.23M | -23.00M | -8.32% |
Dec 31, 2019 | 276.22M | 13.38M | 5.09% |
Dec 31, 2018 | 262.84M | 73.14M | 38.55% |
Dec 31, 2017 | 189.70M | 9.32M | 5.17% |
Dec 31, 2016 | 180.38M | 34.48M | 23.63% |
Dec 31, 2015 | 145.90M | 1.26M | 0.87% |
Dec 31, 2014 | 144.64M | 3.88M | 2.75% |
Dec 31, 2013 | 140.76M | 9.05M | 6.87% |
Dec 31, 2012 | 131.72M | 12.09M | 10.11% |
Dec 31, 2011 | 119.63M | 2.98M | 2.56% |
Dec 31, 2010 | 116.65M | 4.96M | 4.44% |
Dec 31, 2009 | 111.69M | 6.63M | 6.31% |
Dec 31, 2008 | 105.06M | 10.30M | 10.87% |
Dec 31, 2007 | 94.76M | 13.45M | 16.54% |
Dec 31, 2006 | 81.31M | 12.03M | 17.36% |
Dec 31, 2005 | 69.28M | 6.90M | 11.06% |
Dec 31, 2004 | 62.38M | 2.85M | 4.79% |
Dec 31, 2003 | 59.53M | -18.26M | -23.48% |
Dec 31, 2002 | 77.80M | -9.88M | -11.26% |
Dec 31, 2001 | 87.67M | 10.58M | 13.72% |
Dec 31, 2000 | 77.10M | 10.37M | 15.55% |
Dec 31, 1999 | 66.72M | 6.03M | 9.94% |
Dec 31, 1998 | 60.69M | 10.12M | 20.01% |
Dec 31, 1997 | 50.57M | 13.71M | 37.18% |
Dec 31, 1996 | 36.87M | 7.64M | 26.14% |
Dec 31, 1995 | 29.23M | 5.42M | 22.75% |
Dec 31, 1994 | 23.81M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
OPKO Health | 863.50M |
Avanos Medical | 673.30M |
BioCryst Pharmaceuticals | 331.41M |
MiMedx Group | 321.48M |
Simulations Plus | 64.67M |
MacroGenics | 58.75M |
EyePoint Pharmaceuticals | 46.02M |
Relay Therapeutics | 25.55M |
AORT News
- 1 day ago - Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting - PRNewsWire
- 7 days ago - Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results - PRNewsWire
- 4 weeks ago - Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference - PRNewsWire
- 7 weeks ago - Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference - PRNewsWire
- 2 months ago - Artivion Reports Fourth Quarter and Full Year 2023 Financial Results - PRNewsWire
- 3 months ago - Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results - PRNewsWire
- 3 months ago - Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting - PRNewsWire
- 3 months ago - Artivion Obtains $350 Million in Senior Secured Credit Facilities - PRNewsWire